Cetaphil (Galderma Laboratories, L.P.)
Welcome to the PulseAid listing for the Cetaphil drug offered from Galderma Laboratories, L.P.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Galderma Laboratories, L.P. |
NON-PROPRIETARY NAME: | octocrylene, avobenzone |
SUBSTANCE NAME: | OCTOCRYLENE; AVOBENZONE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | TOPICAL |
DOSAGE FORM: | LOTION |
MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
START MARKETING DATE: | 2000-04-01 |
END MARKETING DATE: | 0000-00-00 |
Cetaphil HUMAN OTC DRUG Details:
Item Description | Cetaphil from Galderma Laboratories, L.P. |
LABELER NAME: | Galderma Laboratories, L.P. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10; 3(g/100mL; g/100mL) |
START MARKETING DATE: | 2000-04-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0299-3928_913f1236-84ad-417c-bb77-bb2146ae7bdd |
PRODUCT NDC: | 0299-3928 |
APPLICATION NUMBER: | part352 |
Other OCTOCRYLENE; AVOBENZONE Pharmaceutical Manufacturers / Labelers: